MLCK-dependent phosphorylation of cytoskeletal myosin II increases the metastatic potential of tumor cells, and MLCK-dependent cytoskeleton rearrangement modulates vascular endothelial barrier functions associated with angiogenesis, which is a critical step in cancer development (Dudek and Garcia, 2001). This evidence concerns the gene MYLK2 and neoplasm.